We found that the combination of HVJ-E and PD-1 antibody in tumor tissues enhanced the expression of MHC class I and PD-L1 in a MPM-bearing mouse, and their combined use enhanced the antitumor effect. This evidence concerns the gene PDCD1 and neoplasm.